RETRACTION: Flot2 targeted by miR449 acts as a prognostic biomarker in glioma (Retraction of Vol 47, Pg 250, 2019)

被引：0
|
作者：
Huang, Shaosong
Zheng, Shihao
Huang, Shengyue
Cheng, Hui
Lin, Ying
Wen, Yuxing
Lin, Wei
机构：
来源：
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY | 2021年 / 49卷 / 01期
关键词：
D O I：
10.1080/21691401.2021.2003049
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：679 / 679
页数：1
相关论文
共 50 条
  • [1] Statement of Retraction: Flot2 targeted by miR-449 acts as a prognostic biomarker in glioma (Artificial Cells, Nanomedicine, and Biotechnology, (2019), 47, 1, (250-255), 10.1080/21691401.2018.1549062)
    Artificial Cells, Nanomedicine and Biotechnology, 2021, 49 (01):
  • [2] RETRACTED: Flot2 targeted by miR-449 acts as a prognostic biomarker in glioma (Retracted article. See vol. 49, pg. 679, 2021)
    Huang, Shaosong
    Zheng, Shihao
    Huang, Shengyue
    Cheng, Hui
    Lin, Ying
    Wen, Yuxing
    Lin, Wei
    ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2019, 47 (01) : 250 - 255
  • [3] RETRACTION: MiR-23a-3p acts as an oncogene and potential prognostic biomarker by targeting PNRC2 in RCC (vol 110, pg 656, 2019)
    Quan, Jing
    Pan, Xiang
    Li, Yawen
    Hu, Yimin
    Tao, Lingzhi
    Li, Zuwei
    Zhao, Liwen
    Wang, Jingyao
    Li, Hang
    Lai, Yulin
    Zhou, Liang
    Lin, Canbin
    Gui, Yaoting
    Ye, Jing
    Zhang, Fangting
    Lai, Yongqing
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 177
  • [4] RETRACTION: The circular RNA circ-ITCH acts as a tumour suppressor in osteosarcoma via regulating miR-22 (Retraction of Vol 47, Pg 3359, 2019)
    Ren, Chongmin
    Liu, Jia
    Zheng, Bingxin
    Yan, Peng
    Sun, Yuerong
    Yue, Bin
    ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2021, 49 (01) : 165 - 165
  • [5] RETRACTION: The value of FGF9 as a novel biomarker in the diagnosis of prostate cancer (Retraction of Vol 47, Pg 2241, 2019)
    Cui, Genggang
    Shao, Mingming
    Gu, Xingzhou
    Guo, Hongbo
    Zhang, Shiqing
    Lu, Jianlei
    Ma, Hongbin
    ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2020, 48 (01) : 1293 - 1293
  • [6] RETRACTION: Expression tendency and prognostic value of TCF21 in hepatocellular carcinoma (Retraction of Vol 47, Pg 1466, 2019)
    Lu, Wei
    Yang, Chao
    Du, Peng
    Zhang, Jun-Li
    Zhang, Jia-Cheng
    ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2020, 48 (01) : 1288 - 1288
  • [7] RETRACTION: Nanoscale drug delivery strategies for therapy of ovarian cancer: conventional vs targeted (Retraction of Vol 47, Pg 4066, 2019)
    Gupta, Swati
    Pathak, Yashwant
    Gupta, Manish K.
    Vyas, Suresh P.
    ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2021, 49 (01) : 291 - 291
  • [8] RETRACTION: Long non-coding RNA CCAT2 acts as an oncogene in osteosarcoma through regulation of miR-200b/VEGF (Retraction of Vol 47, Pg 2994, 2019)
    Liu, Juntao
    Kong, Dehai
    Sun, Deping
    Li, Jianmin
    ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2021, 49 (01) : 286 - 286
  • [9] RETRACTION: MiR-532-5p acts as a tumor suppressor and inhibits glioma cell proliferation by targeting CSF1 (Retraction of Vol 23, Pg 8964, 2019)
    Wang, Y. -P.
    Liu, J.
    Liu, D.
    Wang, X. -D.
    Bian, A. -M.
    Fang, D-Z.
    Hui, X. -B.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (13) : 7206 - 7206
  • [10] RETRACTION: Sevoflurane suppresses migration and invasion of glioma cells by regulating miR-146b-5p and MMP16 (Retraction of Vol 47, Pg 3306, 2019)
    Zhang, Le
    Wang, Jun
    Fu, Zhijie
    Ai, YanQiu
    Li, Yanrong
    Wang, Ying
    Wang, Yanping
    ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2022, 50 (01) : 225 - 225
12345